01 PROBLEM STATEMENT
Regulatory Affairs Headcount Scales Linearly with Submission Volume
A pharma company managing FDA, CDSCO, EMA, and TGA submissions found that regulatory affairs capacity was the bottleneck on product launch timelines. Every new submission required proportional RA headcount drafting CTD responses, answering ANDA queries, and responding to IND letters consumed weeks of senior RA time per product.
When the agency issued a query letter, the RA team manually searched through years of prior submissions to find
precedent responses taking days to locate relevant context. Regulatory cycle time directly impacted time-to-market and revenue acceleration. The RA team spent 60-80% of effort on repetitive drafting work that followed known templates and existing submission language but there was no way to automate it without creating compliance risk. Response quality consistency across RA personnel was a concern one RA person might remember precedent
another would not.
02 current challenges
What the Pharma Company was Struggling with
Linear
Headcount scaling
Every new submission required
proportional RA headcount. No
way to decouple regulatory
affairs growth from submission
volume growth
Days
Query response time
When FDA or CDSCO issued a
query letter, RA team spent
days manually searching prior
submissions for precedent
responses.
Risk
Delayed product launch
Cost of delayed approval:
every month saved on a
product launch has measurable
revenue value. Regulatory
cycle time was the constraint.
Inconsistent
Response quality
One RA person remembers
precedent, another does not.
No systematic way to use all
relevant context across past
submissions
03 SOLUTION OVERVIEW
STAR’s Approach – AINE Regulatory Document Assistant
STAR Systems deployed the AINE Regulatory Document Assistant, ingesting submission documents from Veeva
Vault or OpenText for CTD, ANDA, and IND queries using existing submissions as context. Version control via existing
DMS tracks all AI-assisted documents. Regulatory email integration for query letter ingestion from FDA, CDSCO,
EMA, and TGA. CFR 21 Part 11 compliant audit logging on IBM PowerVS for inspection readiness. The RA reviewer
approves all AI drafts before submission – no auto-submission ever. STAR updates the regulatory knowledge base
within 10 days of major FDA or CDSCO guideline changes. Response quality consistency is achieved: Gemini uses all
relevant precedent, not just what one RA person remembers. Regulatory affairs headcount growth is decoupled from
submission volume growth.
AI PATTERN
Gemini Q&A + Drafting Assistant +
Precedent Retrieval
04 WORKFLOW PROCESS
Step-By-Step: How a Regulatory Query Gets a Drafted Response
Step 1 – Submission Ingestion: Historical CTD, ANDA, and IND documents ingested from Veeva Vault or OpenText. Version control tracks all AI-assisted work.
Step 2 – Query Letter Received: FDA, CDSCO, EMA, or TGA sends query letter. Ingested automatically via regulatory email integration.
Step 3 – Precedent Retrieval : Gemini retrieves relevant sections from past submissions that address similar queries. Uses all precedent not just what one RA remembers.
Step 4 – Draft Response: Gemini drafts response using precedent context and existing submission language. Maintains consistency with prior regulatory positions.
Step 5 – RA Approval: Regulatory affairs reviewer approves draft before submission. No auto-submission. CFR 21 Part 11 audit logging captures approval workflow.
Step 6 – Knowledge Base: Update STAR updates regulatory knowledge base within 10 days of major FDA or CDSCO guideline change. No lag on new requirements.
05 KEY FEATURES
What the Assistant Does
Gemini Q&A; Over CTD, ANDA, IND:
RA personnel ask questions about past submissions in natural language. Gemini retrieves relevant sections from historical CTD, ANDA, and IND documents automatically.
Drafting Assistant with Precedent:
When query letter arrives, Gemini drafts response using all relevant precedent from existing submissions. Maintains consistency with prior regulatory positions.
Veeva Vault or OpenText Integration:
Submission documents ingested from Veeva Vault or OpenText automatically. Version control via existing DMS tracks all AI-assisted documents for audit trail.
CFR 21 Part 11 Audit Logging:
Complete audit trail of AI-assisted regulatory work logged on IBM PowerVS for FDA inspection readiness. Every draft, revision, and approval captured.
RA Reviewer Approval Workflow:
Regulatory affairs reviewer approves all AI drafts before submission. No auto-submission ever – human judgment retained on every agency response.
CRegulatory Knowledge Base Updates:
STAR updates knowledge base within 10 days of major FDA or CDSCO guideline change. RA team never works against outdated regulatory requirements.
06 BUSINESS OUTCOMES
What Changes After Go-Live
Faster
Regulatory cycle timeDecoupled
RA headcount from submission
volumeConsistent
Response quality across RA teamCompliant
CFR 21 Part 11 audit trailCEO
- Regulatory cycle time reduction: faster FDA and CDSCO responses accelerate product revenue.
- Competitive advantage through regulatory responsiveness.
CFO
- Regulatory affairs headcount growth decoupled from submission volume.
- Cost of delayed approval: every month saved on product launch has revenue value.
CXO / Risk
- Response quality consistency: AI uses all relevant precedent, not just what one RA person remembers.
- Complete audit trail for FDA inspection readiness.
RA Head
- RA team capacity freed from repetitive drafting work for higher-value regulatory strategy.
- Query response time reduced from days to hours.
07 REAL-WORLD SCENARIO
A Day in the Life – Before and After
| Before | After |
|---|
| FDA issues ANDA query letter on a stability study. Senior RA spends 3 days manually searching through 5 years of past submissions to find precedent responses. | FDA query letter arrives. Gemini retrieves all relevant stability study precedent from existing ANDAs in minutes. RA reviewer drafts response in hours, not days. |
| Company files 8 new submissions this quarter. RA headcount needs to increase proportionally hiring 2 more RA personnel to maintain cycle time. | Company files 8 new submissions. AI assistant handles repetitive drafting work. Existing RA team maintains cycle time without headcount increase. |
| Two different RA personnel draft responses to similar queries. One remembers precedent from 3 years ago, the other does not. Responses are inconsistent. | All RA personnel use the same AI assistant with access to all precedent. Response quality is consistent across the team regardless of individual memory. |
| FDA audit asks for documentation trail on AI-assisted regulatory work. RA team has no systematic audit log scrambles to reconstruct approval history. | FDA audit asks for AI-assisted work trail. CFR 21 Part 11 compliant audit log on IBM PowerVS provides complete documentation instantly. |
08 ROI AND VALUE JUSTIFICATION
Why this Numbers Work
| Value Driver | Indicative Impact | How It Is Realised |
|---|
| Regulatory cycle time | Measurably reduced | Faster query response time accelerates product approval. Every month saved on a product launch has direct revenue value. |
| RA headcount scaling | Decoupled from submission volume | AI handles repetitive drafting work that consumes 60-80% of RA effort. Existing team scales sub-linearly with submission growth. |
| Response quality consistency | Across all RA personnel | Gemini uses all relevant precedent from existing submissions, not just what one RA person remembers. Regulatory position consistency maintained. |
| Positive ROI timeline | Within 9-12 months of go live | Revenue acceleration from faster product launches and RA capacity savings on even a modest submission volume exceed platform costs within four quarters. |
09 NEXT STEPS
01
Discovery Call
30-min call to understand your submission volume, current RA cycle time, and regulatory affairs capacity constraints.
02
Pilot Scoping
We identify 3-5 recent query letters for retrospective response drafting. Pilot runs on historical data to measure AI response quality.
03
Pilot Delivery
AI drafts responses to your historical queries. RA team reviews quality and precedent retrieval accuracy over 4-6 weeks.
04
Business Case
Cycle time improvement, RA capacity freed, and response quality consistency measured from your pilot and presented to leadership.
